Ofatumumab: A Novel Anti‑CD20 Monoclonal Antibody for Multiple Sclerosis: A Review of Clinical Considerations

William T. Barham, LSU Health Sciences Center - New Orleans
Katie Dillman, LSU

This paper has been withdrawn.
 
Apr 1st, 12:00 AM Apr 1st, 12:00 AM

Ofatumumab: A Novel Anti‑CD20 Monoclonal Antibody for Multiple Sclerosis: A Review of Clinical Considerations

https://digitalscholar.lsuhsc.edu/mrd/2024mrd/mrd2024/1